Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism.
暂无分享,去创建一个
D. Barron | E. Offord | Á. Gil-Izquierdo | C. Morand | S. Pinaud | M. Horcajada | V. Habauzit | S. Sacco | A. Trzeciakiewicz
[1] D. Kalu,et al. Male rodent model of age-related bone loss in men. , 2001, Bone.
[2] J. Kyle,et al. Flavonoids in foods. , 2006 .
[3] B. Dawson-Hughes,et al. Nutritional Aspects of Osteoporosis , 1998, Proceedings in the Serono Symposia USA Series.
[4] M. Nanes. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. , 2003, Gene.
[5] S. Anton,et al. Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.
[6] A. Scalbert,et al. Flavanone metabolism in healthy and tumor-bearing rats. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[7] I. Reid. Relationships between fat and bone , 2008, Osteoporosis International.
[8] M. Horcajada,et al. Hesperidin, a Citrus Flavanone, Improves Bone Acquisition and Prevents Skeletal Impairment in Rats , 2004 .
[9] C. Cooper,et al. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. , 2007, QJM : monthly journal of the Association of Physicians.
[10] E. Offord,et al. Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats. , 2008, Journal of applied physiology.
[11] S. Harris,et al. Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.
[12] C. Filesi,et al. Polyphenols, intracellular signalling and inflammation. , 2007, Annali dell'Istituto superiore di sanita.
[13] D. Mellström,et al. Older men with low serum IGF‐1 have an increased risk of incident fractures: The MrOS Sweden study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] D. Barron,et al. Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats , 2009, British Journal of Nutrition.
[15] H. Vezin,et al. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[16] K. Setchell,et al. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. , 2003, The American journal of clinical nutrition.
[17] P. Jansen,et al. Nitrite and nitrate determinations in plasma: a critical evaluation. , 1995, Clinical chemistry.
[18] Seaver,et al. Nitric oxide as a secretory product of mammalian cells , 2004 .
[19] G. Leone,et al. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids , 1990, British journal of haematology.
[20] H. Chung,et al. Modulation of the age‐related nuclear factor‐κB (NF‐κB) pathway by hesperetin , 2006, Aging cell.
[21] Gary Williamson,et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.
[22] A. Scalbert,et al. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. , 2005, Life sciences.
[23] M. Horcajada,et al. Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. , 2010, The Journal of nutritional biochemistry.
[24] S. Wimalawansa,et al. Nitric oxide and bone , 2010, Annals of the New York Academy of Sciences.
[25] T. Mathevon,et al. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites , 2006, European journal of nutrition.
[26] C. Manach,et al. Influence of dietary antioxidants on polyphenol intestinal absorption and metabolism in rats. , 2006, Journal of agricultural and food chemistry.
[27] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[28] M. Centrella,et al. Local IGF-I expression and bone formation. , 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[29] Hiroshi Takayanagi,et al. The molecular understanding of osteoclast differentiation. , 2007, Bone.
[30] Y. Ikoma,et al. Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. , 2004, Journal of agricultural and food chemistry.
[31] S. Garg,et al. Chemistry and pharmacology of the citrus bioflavonoid hesperidin , 2001, Phytotherapy research : PTR.
[32] Herbert A Wetli,et al. Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. , 2003, The Journal of nutrition.
[33] S. Robins. Biochemical markers for assessing skeletal growth. , 1994, European journal of clinical nutrition.
[34] E. Keller,et al. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.
[35] S. Adami,et al. Relationship Between Lipids and Bone Mass in 2 Cohorts of Healthy Women and Men , 2004, Calcified Tissue International.
[36] J. Corton,et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.
[37] N. Omi,et al. The effect of ovariectomy on bone metabolism in rats. , 1995, Bone.
[38] D. Jacobs,et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. , 2007, The American journal of clinical nutrition.
[39] B. Patil,et al. Citrus juice modulates bone strength in male senescent rat model of osteoporosis. , 2006, Nutrition.
[40] T. Foroud,et al. Variability in Skeletal Mass, Structure, and Biomechanical Properties Among Inbred Strains of Rats , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] Liliana Jiménez,et al. Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.
[42] Kazuki Kanazawa,et al. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. , 2003, The Journal of nutrition.
[43] A. Rubinacci,et al. Total and free deoxypyridinoline after acute osteoclast activity inhibition. , 1999, Clinical chemistry.
[44] J. Cook,et al. Factors Influencing the Assay of Creatinine , 1975, Annals of clinical biochemistry.
[45] C. Ding,et al. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. , 2008, The Journal of clinical endocrinology and metabolism.
[46] J. Larsen,et al. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. , 1998, Chemical research in toxicology.
[47] M. Allen. Biochemical markers of bone metabolism in animals: uses and limitations. , 2003, Veterinary clinical pathology.
[48] B. Patil,et al. Feeding orange pulp improved bone quality in a rat model of male osteoporosis. , 2009, Journal of medicinal food.
[49] S. Khosla,et al. Physiology of bone loss. , 2010, Radiologic clinics of North America.
[50] C H Turner,et al. Basic biomechanical measurements of bone: a tutorial. , 1993, Bone.
[51] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[52] G. Wolf. Energy regulation by the skeleton. , 2008, Nutrition reviews.
[53] K. Son,et al. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. , 1999, The Journal of nutrition.
[54] D. Barron,et al. Molecular mechanism of hesperetin-7-O-glucuronide, the main circulating metabolite of hesperidin, involved in osteoblast differentiation. , 2010, Journal of agricultural and food chemistry.
[55] S. Oikawa,et al. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. , 2000, Biochemical and biophysical research communications.
[56] M. Nanes. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. , 2003, Gene.